Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Open Water Rx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Open Water Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 245 · Grade C

Open Water Rx

Visit Open Water Rx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

That doesn't make Open Water Rx a bad call — it's best for readers who want one flat, all-inclusive monthly price that does not rise with the dose. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
54
Transparency
90
94
Access Breadth
93
62
Clinical Oversight
92
54
Track Record
88
40
CoreAge RxBrief Score 94 · 66Open Water Rx

Price, coverage & the tracker

CoreAge RxOpen Water Rx
Brief Score94/100 (A)66/100 (C)
Semaglutide$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published$169/mo (all doses, compounded)
Tirzepatide$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published$219/mo (all doses, compounded)
CoverageUS only; restrictions by state, confirmed at intakeMost U.S. states (the site's own wording; no full list published)
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
On the trackerStableprice stableFallingprice falling

CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.

Open Water Rx: Re-read on the provider's own pricing page on 24 September 2026: compounded semaglutide is $169 and tirzepatide $219 for one month, the same at every dose, with shipping and the clinician review included. That is lower than the figures we first carried, so the direction is down. Three- and six-month plans lower the monthly cost further.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.